Tumor angiogenesis as prognostic and predictive marker for chemotherapy dose-intensification efficacy in high-risk breast cancer patients within the WSG AM-01 trial

By Gluz Oleg  

Breast Cancer Research and Treatment, Vol. 126, Iss. 3, 2011-04 ,pp. : 643-651

Springer Publishing Company

Access to resources Recommend Favorite

Advancements in the use of blood tests for cancer screening in women at high risk for endometrial and breast cancer

By Ambeba Erica   Linkov Faina  

Future Oncology, Vol. 7, Iss. 12, 2011-12 ,pp. : 1399-1414

Future Medicine

Access to resources Recommend Favorite

NPY1R is a novel peripheral blood marker predictive of metastasis and prognosis in breast cancer patients

By  

Oncology Letters, Vol. 9, Iss. 2, 2015-01 ,pp. : 891-896

Spandidos Publications

Access to resources Recommend Favorite

HER2 as a prognostic and predictive marker for breast cancer

By Cooke T.   Reeves J.   Lanigan A.   Stanton P.  

Annals of Oncology, Vol. 12, Iss. 12, 2001-12 ,pp. : 23-28

Springer Publishing Company

Access to resources Recommend Favorite

TrkC: A New Predictive Marker in Breast Cancer?

By Blasco-Gutierrez Maria Jesus   Jose-Crespo Isabel Julia San   Zozaya-Alvarez Enrique   Ramos-Sanchez Rafael   Garcia-Atares Natividad  

Cancer Investigation, Vol. 25, Iss. 6, 2007-09 ,pp. : 405-410

Informa Healthcare

Access to resources Recommend Favorite